Evidence map›Paper›PMID 25435942›Full record

ArticleOncology letters2015

Peripheral primitive neuroectodermal tumor of the kidney in a 51-year-old female following breast cancer: A case report and review of the literature.

Jinjing Zhong, Ni Chen, Xueqin Chen, Jing Gong, Ling Nie, Miao Xu, Qiao Zhou

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Primary Renal Ewing Sarcoma in Children and Young Adults.Journal of pediatric hematology/oncology · 2020
    Article
  3. Article
  4. Primary pericardial primitive neuroectodermal tumor: a case report and review of literature.International journal of clinical and experimental pathology · 2018
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jinjing ZhongDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Ni ChenDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Xueqin ChenDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Jing GongDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Ling NieDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Miao XuDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Qiao ZhouDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral primitive neuroectodermal tumor/Ewing's sarcoma (pPNET/EWS) is an aggressive type of sarcoma that is rarely observed in the kidney. pPNET of the kidney principally occurs in young patients (<50 years old) and is very rare in older patients (≥50 years old). Additionally, only six cases of pPNET of the kidney have been reported in the literature in older patients (≥50 years old), and pPNET as a secondary primary tumor has rarely been reported. The current study presents a case of renal pPNET in a 51-year-old female who had been surgically treated for breast carcinoma and administered with adjuvant chemotherapy five years prior to hospitalization for pPNET. A computed tomography scan identified a tumor in the lower pole of the right kidney, which was treated by nephrectomy. Immunohistochemistry demonstrated diffuse, strong membranous positivity for cluster of differentiation (CD)99, positive nuclear staining for friend leukemia integration 1, and negative staining for Wilms' tumor 1 and other markers. Fluorescence

Indexed as

adjuvant therapybreast adenocarcinomaEwing sarcoma breakpoint region 1fluorescent in situ hybridizationimmunohistochemistryrenal peripheral primitive neuroectodermal tumor

Identifiers

PMID25435942
PMCPMC4246623
OpenAlexW2113684711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.